← Back to Search

Behavioral Intervention

Speech-to-noise feedback for Parkinson's Disease

N/A
Waitlist Available
Led By Scott Adams, PhD
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up single two-hour visit.
Awards & highlights

Study Summary

This study will evaluate the effectiveness of a speech-to-noise feedback procedure for the treatment of hypophonia in Parkinson's disease. The procedure includes a device that records the sound intensity level of the wearer's speech and compares it to the noise level around them. The device will provide the wearer with feedback if their speech becomes too quiet for them to be heard by their listener.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~single two-hour visit.
This trial's timeline: 3 weeks for screening, Varies for treatment, and single two-hour visit. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Average speech-to-noise ratio
Secondary outcome measures
Percent Speech Intelligibility Score (PSIS)
Ratings of Experience with the Device

Trial Design

1Treatment groups
Experimental Treatment
Group I: Speech-to-noise feedbackExperimental Treatment1 Intervention
A target speech-to-noise level is specified and feedback about achievement of the target level is provided

Find a Location

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor
656 Previous Clinical Trials
413,403 Total Patients Enrolled
University of Western Ontario, CanadaOTHER
164 Previous Clinical Trials
319,221 Total Patients Enrolled
Scott Adams, PhDPrincipal InvestigatorWestern University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Evaluation of a Speech-to-noise Feedback Device for Treatment of Hypophonia in Parkinson's Disease
2019. "Evaluation of a Speech-to-noise Feedback Device for Treatment of Hypophonia in Parkinson's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03648749.
All > Parkinson
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top